Skip to main content
OpenTrials
Completed

NCT Number: NCT02664324

MSPT Device Usability Study

The primary objective of this feasibility study is to evaluate the functionality (e.g., as defined by the primary endpoints) of the fully integrated Multiple Sclerosis Performance Test (MSPT) device, when used by unsupervised participants with MS, or related conditions, with a broad range of disability, in multi-clinical-care environments. Secondary objectives include: Participant perception of usability of device; Participant satisfaction with the device; Ascertain the impact of different clinical environments on device usability; Ascertain impact of assistive devices in usability of device; Ascertain functionality of Bluetooth remote as compared with manual timing.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Multiple Sclerosis Autoimmune Diseases Autoimmune Diseases of the Nervous System Demyelinating Autoimmune Diseases, CNS Demyelinating Diseases Immune System Diseases Nervous System Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Baltimore, Maryland, United States

Loading trial locations.

About this study

This study does not involve evaluation(s) of the clinical efficacy of the MSPT device or the efficacy of MS therapies. This feasibility study is examining the usability of the fully integrated MSPT device. Study participants will be enrolled for same-day testing.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Key Inclusion Criteria:

  • Diagnosis of MS, or related conditions, such as: Clinically Isolated Syndrome (CIS), Neuromyelitis Optica (NMO), and Transverse Myelitis (TM)
  • Literacy of written English language as displayed on software tool
  • Ability to understand and comprehend software tool from the audio and visual instructions provided in English

Key Exclusion Criteria:

  • Study participants, who in the opinion of the Investigator, have vision impairment that precludes their ability to see the iPad Air2® screen/MSPT device.
  • Neurological illnesses/conditions, such as motor or vocal tics (including a diagnosis of Tourette's syndrome), head trauma with significant loss of consciousness (>30 minutes), cerebral palsy, dementia (including mild cognitive impairment and Alzheimer's disease), chronic meningitis, Parkinson's disease, and Huntington's disease.

NOTE: Other protocol defined Inclusion/ Exclusion criteria may apply.

Treatment and study plan

Primary outcomes

  1. Number of study participants successfully completing all modules of the MSPT device

    Time frame: Through study duration (3-4 hours)

    The MSPT software tool builds upon previously validated measures comprising the Multiple Sclerosis Functional Composite (MSFC) that represents a comprehensive functional assessment of MS participants that include: MyHealth: MS -Patient demographic, health and medication information; NeuroQoL - Neurological Quality of Life test -Participant reported; PST Processing Speed Test- Measures mental processing speed; Contrast Sensitivity Test (CST)- 50cm vision test; MDT Manual Dexterity Test- 9 hole peg test; WST Walking Speed Test - Timed 25 foot walk

  2. Percent (%) of study participants successfully completing all modules of the MSPT device

    Time frame: Through study duration (3-4 hours)

Secondary outcomes

  1. Percent (%) of study participants who select agree/strongly agree (questions 1 to 5) or disagree/ strongly disagree (questions 6-9) on appropriate questions on the MSPT Usability Survey

    Time frame: Through study duration (3-4 hours)

    MSPT usability survey is a 10 item paper-based questionnaire to measure participant perception of the usability of the device. A study participant will meet the usability secondary endpoints if usability (agree/strongly agree or disagree/strongly disagree, as appropriate) is selected for 6 or more survey questions.

  2. Percent (%) of study participants who reported being satisfied or completely satisfied with using MSPT device

    Time frame: Through study duration (3-4 hours)

    MSPT satisfaction survey is a 1 item paper-based questionnaire to measure participant satisfaction with the MSPT device.

  3. Difference of manual timed versus Bluetooth timed in Walking Speed Test (WST) as assessed by Timed 25 foot walk

    Time frame: Through study duration (3-4 hours)

    T25FW is a quantitative mobility and leg function performance test where the participant is timed while walking for 25 feet.

  4. The percent (%) of study participants who have usability issues with Bluetooth remote due to use of an assistive device(s)

    Time frame: Through study duration (3-4 hours)

  5. Between-site differences in percent (%) of study participants who select agree/strongly agree (questions 1 to 5) or disagree/ strongly disagree (questions 6 to 9) on appropriate questions on the MSPT Usability Survey

    Time frame: Through study duration (3-4 hours)

  6. Between-site differences in percent (%) of study participants who select satisfied/completely satisfied on MSPT Satisfaction Survey

    Time frame: Through study duration (3-4 hours)

Sponsors and collaborators

Lead sponsor

Biogen

Industry

Registry information

Official study title

The Multiple Sclerosis Performance Test (MSPT) Device for Functional Assessment of Multiple Sclerosis (MS) Patients

Acronym: MSPT

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Jan 27, 2016
Registry last updated
May 4, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.